• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy

Vertex invests in patient community and future docs with $500m commitment

October 17, 2017 By Sarah Faulkner

Vertex PharmaBoston-based Vertex Pharmaceuticals (NSDQ:VRTX) announced today that it plans to spend $500 million over 10 years in support of an array of initiatives – including a $50 million investment in science, technology, engineering, arts and math education for underserved students and young women.

Vertex is also extending its collaboration with Boston’s public school system, giving students access to Vertex’s 3,000 square foot learning lab, along with mentoring and internship opportunities and full scholarships to the University of Massachusetts.

“Giving back is part of who we are at Vertex – it’s in our DNA,” president, chairman & CEO Dr. Jeffrey Leiden said in prepared remarks. “This new 10-year commitment will provide many more opportunities for Vertex and its employees to make a difference in the lives of people with serious diseases and those living in our communities.”

The company said that its corporate giving commitment with focus on the cystic fibrosis patient community and its ability to access Vertex’s medicines, STEAM education, supporting young physicians and fostering an ecosystem of innovation in the company’s local communities.

“For Vertex, innovative ideas that transform lives have never been restricted to lab rooms,” congressman Joe Kennedy III (D-Mass.) said. “With this investment in their neighbors, patients, and local students, Vertex can both strengthen their community today and expand our Commonwealth’s workforce of tomorrow.”

“In Boston, we are lucky to have companies like Vertex stepping up and contributing to our city and our future workforce,” Boston mayor Martin Walsh added. “This commitment will mean thousands of students across the City will continue to have the opportunity to get hands-on experiences in STEAM and see a place for themselves in Boston’s thriving innovation economy.”

The pharma company also said that it will launch The Vertex Foundation next year, with an initial gift of $10 million.

Filed Under: Featured, Pharmaceuticals, Wall Street Beat Tagged With: vertexpharmaceuticals

IN CASE YOU MISSED IT

  • Tandem Diabetes Care delivers 1 million insulin boluses using t:connect mobile app
  • Nuvo, Sheba Medical Center develop AI-powered gestational diabetes management platform
  • Verily’s Onduo, Sword Health collaborate on virtual diabetes care
  • Shareholder lawsuit over BD’s Alaris pumps recall moves forward
  • Embecta stock soars on first full-quarter results after BD spinoff

Primary Sidebar

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Need Drug Delivery Business News in a minute? We Deliver!
Drug Delivery Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

Signup for the newsletter

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing & Extrusion
Medical Design & Outsourcing
MedTech100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
Advertise with us
About
Contact us
Privacy
Listen to our Weekly Podcasts
Add us on FacebookFollow us on TwitterConnect with us on LinkedIn

Copyright © 2022 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS